Lotilaner | USP/EP-Certified Parasiticide API | Bulk Supplier for Pet Parasite Control
Google Keywords: Lotilaner bulk supplier, GABA receptor antagonist API, flea and tick treatment, USP-certified veterinary API
🌟 Product Overview
Lotilaner (CAS 1369852-71-0) is a non-competitive antagonist targeting insect GABA<sub>Cl</sub> receptors, specifically effective against fleas, ticks, and mites in pets13. It disrupts neurotransmission in parasites, leading to rapid paralysis and death13. Approved for veterinary use in dogs and cats, it is a key ingredient in commercial antiparasitic formulations15.
✔️ Key Advantages
High Purity: ≥99% HPLC purity compliant with USP/EP standards14.
Bulk Packaging: Available in 1g–25kg batches with COA, MSDS, and stability testing12.
Solubility: White crystalline powder soluble in DMSO (up to 25 mg/ml) for oral or topical formulations13.
🏥 Applications
Flea & Tick Control: Primary treatment in topical/oral pet medications13.
Veterinary Pharmaceuticals: Formulated for dogs and cats to prevent parasitic infestations14.
Research: Reference standard for studying insecticide resistance mechanisms35.
📜 Quality Compliance
Certified under USP/EP guidelines with residual solvents <10ppm and heavy metals <20ppm14.
Stability tested for 24 months at -20°C in airtight, light-protected containers14.
📈 Market Trends
The global pet parasite treatment market is projected to grow at 6.8% CAGR (2025-2030), driven by rising pet ownership and demand for safe, fast-acting solutions like Lotilaner13. Its selective action on insect GABA receptors ensures minimal impact on mammals13.
China
